Imaging biomarkers in DME and RVO: from disease development to treatment

This advanced course explores the role of imaging biomarkers in the diagnosis, monitoring, and treatment of diabetic macular oedema and retinal vein occlusion. Through high-resolution OCT, OCT-angiography, multimodal imaging, and artificial intelligence applications, participants will gain a deeper understanding of disease mechanisms and learn how to translate imaging findings into personalized, evidence-based therapeutic decisions.

ESASO Scientific Director: Mario Romano
Course Scientific Coordinator: JosΓ© Medel

This course has been accredited with 16 CME Credits

Teaching language: English πŸ‡¬πŸ‡§

Next Course in 2027 🎯

Only 20 seats available πŸ”₯

⭐⭐⭐⭐⭐ More than 1700 students

πŸŽ—οΈ This course awards you with 1/5 MDHO Points

What you'll learn

βœ”οΈ

How to identify clinically relevant OCT and OCT-A biomarkers in DME and RVO

βœ”οΈ

How retinal ischemia and structural changes influence disease progression

βœ”οΈ

How multimodal imaging improves diagnostic accuracy and treatment planning

βœ”οΈ

How imaging biomarkers guide therapeutic choices, including treatment switching

Skills you'll acquire

Advanced OCT and OCT-A interpretation

Imaging-based clinical decision-making

Biomarker-driven treatment selection

Multimodal retinal imaging analysis

Early identification of disease progression

From

Free

Pay later with Β 

Take me to the registration form

Date: 13 May 2026
Venue: Online on eLOS
Level: Advanced

This course includes:

πŸ§‘πŸ»β€πŸ«2 educational hours
πŸ§‘πŸ»β€πŸ« International, experienced Faculty
⬇️ Downloadable resources
πŸ—¨οΈ eLOS account
πŸ¦ΈπŸ»β€β™‚οΈ Assistance of Event Manager
πŸ… Accreditation Certificate
πŸ“œ ESASO Certificate of Attendance
πŸ‡¨πŸ‡­ Swiss-level organisation

Course sponsorIndependent support grant

Course Programme